共 50 条
- [31] The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple SclerosisJAMA NEUROLOGY, 2014, 71 (11) : 1421 - 1428Ireland, Sara J.Guzman, Alyssa A.O'Brien, Dina E.Hughes, SamuelGreenberg, BenjaminFlores, AngelaGraves, DonnaRemington, GinaFrohman, Elliot M.Davis, Laurie S.Monson, Nancy L.
- [32] The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosisMULTIPLE SCLEROSIS JOURNAL, 2016, 22 (04) : 520 - 532Warrender-Sparkes, MatthewSpelman, TimIzquierdo, GuillermoTrojano, MariaLugaresi, AlessandraGrand'Maison, FrancoisHavrdova, EvaHorakova, DanaBoz, CavitOreja-Guevara, CeliaAlroughani, RaedIuliano, GerardoDuquette, PierreGirard, MarcTerzi, MuratHupperts, RaymondGrammond, PierrePetersen, ThorFernandez-Bolanos, RicardoFiol, MarcelaPucci, EugenioLechner-Scott, JeannetteVerheul, FreekCristiano, EdgardoVan Pesch, VincentPetkovska-Boskova, TatjanaMoore, FraserKister, IlyaBergamaschi, RobertoLaura Saladino, MariaSlee, MarkBarnett, MichaelAmato, Maria PiaShaw, CameronShuey, NeilYoung, CarolynGray, OrlaKappos, LudwigButzkueven, HelmutKalincik, TomasJokubaitis, Vilija
- [33] Clinical Efficacy of Laquinimod for the Treatment of Multiple Sclerosis; Pooled Analyses from the ALLEGRO and BRAVO Phase III TrialsNEUROLOGY, 2012, 78Vollmer, TimothyComi, GiancarloSorensen, Per SolbergArnold, DouglasFilippi, MassimoStatinova, OlenaKobys, TetyanaBecker, ElkeJeffery, DouglasMontalban, XavierKappos, LudwigBoyko, AlexeySelmaj, KrzysztofZipp, FraukeHavrdova, EvaCohen, Jeffrey
- [34] Pharmacokinetic evaluation in a double blind, randomised, phase II study of oral laquinimod versus placebo in patients with relapsing multiple sclerosisMULTIPLE SCLEROSIS, 2004, 10 (7032): : S259 - S259Nordle, OSparre, BLinde, ANederman, TGunnarsson, PO
- [35] ARPEGGIO: Design of a Randomized, Placebo-Controlled Study to Evaluate Oral Laquinimod in Patients with Primary Progressive Multiple Sclerosis (PPMS)MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (02) : 335 - 336Kolodny, S.Giovannoni, G.Grinspan, A.Hartung, H. -P.Cree, B. A. C.Barkhof, F.Uccelli, A.Sormani, M. P.Krieger, S.Uitdehaag, B. M. J.Montalban, X.Steinerman, J. R.Knappertz, V.
- [37] Fingolimod Induced Cytokine Profile in Cultured Monocytes from Multiple Sclerosis PatientsNEUROLOGY, 2013, 80Achiron, AnatFalb, RinaDolgopiat, Mark DolevMagalashvili, DavidGurevich, Michael
- [38] The effects and side effects of laquinimod for the treatment of multiple sclerosis patients: a systematic review and meta-analysis of clinical trialsEUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (05) : 611 - 622Rouhi, FaezeMohammadpour, ZinatNoureini, Sakineh KazemiAbbastabar, HedayatHarirchian, Mohammad HosseinBitarafan, Sama
- [39] The effects and side effects of laquinimod for the treatment of multiple sclerosis patients: a systematic review and meta-analysis of clinical trialsEuropean Journal of Clinical Pharmacology, 2020, 76 : 611 - 622Faeze RouhiZinat MohammadpourSakineh Kazemi NoureiniHedayat AbbastabarMohammad Hossein HarirchianSama Bitarafan
- [40] Effect of laquinimod, a novel immunomodulator in development for treatment of multiple sclerosis, on cardiac repolarization in healthy subjects: a thorough QT/QTc studyMULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 318 - 319Elgart, A.Mimrod, D.Rabinovich-Guilatt, L.Eyal, E.Morganroth, J.Spiegelstein, O.